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Transplantation for primary hyperoxaluria in the United States. patients has improved significantly [1]. In Europe, with
Background. Transplantation (TX) has become an accept- poor results of isolated kidney transplantation (KTX),
able treatment for renal failure in primary hyperoxaluria (PH). primarily from cadaveric donors performed before 1986,We have analyzed data from three U.S. sources to estimate
combined kidney-liver transplant (K/LTX) has predomi-the success or failure of different modes of management in PH
patients. nated [2]. With referral to highly specialized centers com-
Methods. The United States Renal Data System (USRDS) mon, the European consortium has systematically col-
tapes provided coded medical record data, with PH assigned lected data on K/LTX [3].to 235 patients from 1974 to 1996. Another 45 patients were
To establish results in the United States without afound from USRDS hospitalization records. We limited patients
to those developing end-stage renal disease at ,55 years of central registry, we queried all of the available databases
age after 1984 (95 PH patients). The North American Pediatric with more extensive data [4] and have combined that
Renal Transplantation Cooperative Study (NAPRTCS) identi- data to develop a comprehensive pattern. We show thatfied 34 (11 new) PH patients, and the United Network for
TX for PH in the United States is a better option thanOrgan Sharing (UNOS) database identified PH in 34 (16 new,
NoTX because of the lesser risk of KTX. It appears that5 more in both UNOS and NAPRTCS) patients. These second-
ary sources were used to correct some data from the USRDS KTX currently remains a safer option than K/LTX for
and to add 32 more patients, with a total of 128 PH patients. the patient with PH, recognizing that a meticulous proto-
Considering kidney TX (KTX) prior to combined kidney/liver
col is necessary. K/LTX is still a surgical procedure withTX (K/LTX) as a separate record for some calculations, the
considerable risk for patient survival, although poten-total “cases” were 138.
Results. By life table analysis, the 94 total TX patient survival tially curative. Although the proportion of patients re-
was better than for the 34 NoTX patients (P , 0.001). The 52 ceiving K/LTX has increased, the survival figures have
KTX patients’ survival was better than either the 32 primary
not yet matched those of KTX.K/LTX (P , 0.001) or the 10 K/LTX that following KTX (P ,
0.001). The 62 KTX cases’ survival was better than the 42
K/LTX cases (P , 0.005), which did not differ from the 34
METHODSNoTX (P , 0.67). The overall survival of these 62 KTX patients
was 76%. The survival of 42 K/LTX was 69%, and the survival Data collection
of 34 NoTX patients was 44%. Kidney graft life table projected
Data from the United States Renal Data Systemsurvival curves for TX patients did not differ between K/LTX
(56% at 6 years) and isolated KTX (51% at 6 years, 35% at (USRDS) was provided to the investigators as limited
10 years, P , 0.91). SAS transport data sets after application and permissionConclusion. KTX offers better patient survival in the United
from the USRDS scientific committee. Records datedStates then either K/LTX or NoTX. Graft survival does not
differ between KTX and K/LTX. Because K/LTX can still follow from 1974 until 1996. The original source for the USRDS
a failed KTX, isolated living related donor KTX is still a reason- data was derived from Health Care Finances Adminis-
able first option for PH type 1 if a strictly managed protocol is tration (HCFA)-supported financial coverage of end-followed.
stage renal disease (ESRD). Privacy of all data was main-
tained, and identifying data were excluded throughout
the study. Dates of transplant, sex, race, age, and regionSince 1984, our understanding of the pathogenesis and
of transplant were used to exclude duplication and totransplant management of primary hyperoxaluria (PH)
match patients in the different databases. The USRDS
data were considered comprehensive, likely including allKey words: oxalate, hyperoxaluria, renal transplant, kidney-liver trans-
plant. patients with possible TX insurance coverage through
Medicare or Medicaid. There was no check on diagnosticReceived for publication September 1, 1998
codes entered at the time of ESRD registration. Theseand in revised form February 2, 1999
Accepted for publication March 25, 1999 codes were not usually changed by USRDS when later
information suggested a different diagnosis. Patients not 1999 by the International Society of Nephrology
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covered by Medicare or Medicaid, such as primary liver Data analysis
transplant (LTX), foreign nationals, and independently Transport data sets were imported into SAS, a statisti-
funded patients, may not have been included. cal package from SAS Institute (Cary, NC, USA), and
The ICD-9 diagnostic code for hyperoxaluria (ICD9- analyses were performed on subsets of this data using
2718) was assigned to 235 patients in the USRDS from SAS version 6.08 on a DEC/VAX 6000-620 mainframe
1974 to 1996. Using hospitalization records and trans- computer and version 6.11 on a IBM RS 6000 mainframe
plant follow-up files to examine discharge diagnostic codes computer. Graphic processing used SigmaPlot 4.0 for
and surgical procedure codes, another 45 PH patients Windows (Jahndel).
Life table analysis. The frequency and life table statis-were found. The high mean age of the 280 patients (44.4 6
tical procedures were performed using the actuarial ap-23.4 sd years) was considered unlikely for PH. This sug-
proach [5]. Differences between two or more groupsgested a questionable diagnosis in older patients, possibly
were analyzed by log-rank [6] and Wilcoxon test [7].secondary oxalosis caused by long-term dialysis therapy.
Log-rank data better reflected the earlier time periods,For this reason, we arbitrarily excluded patients entering
when greater patient numbers were available. P valuesESRD after the age of 55 years and those before 1984,
of less than 0.05 were considered significant.when our aggressive approach was reported [1]. A few
more were excluded whose data would have clearly ex-
cluded PH (that is, multiple hospitalizations for diabetes RESULTS
mellitus and systemic lupus erythematosis). By searching Of the 95 patients from the USRDS limited to less
the USRDS surgical procedures and hospitalization dis- than 55 years of age and entering ESRD since 1984, the
charge codes, 12 transplanted patients who had also re- age was now 30 6 17 years (Table 2). Sixty-one had
ceived a liver transplant were identified. transplants (age 25.84 6 16), and 34 had NoTX (age 39 6
Coded data were obtained from the United Network 13 years, P , 0.001). One hundred and twenty-eight PH
for Organ Sharing (UNOS), the organization that distrib- patients were analyzed in the database expanded by the
utes primarily cadaveric organs for TX. Only the K/LTX UNOS and NAPRTC data. The age was 39 6 12 years
data included appropriate diagnostic codes, including 34 for the 34 nontransplanted patients and 22 6 16 years
transplants for PH, and were available for the years 1984 for the 94 in the TX group (P , 0.0001; Fig. 1). NoTX
through 1996. It was felt that the diagnostic codes were primarily occurred in patients older than 20 (30 out of
relatively reliable, and because most U.S. K/LTX organs 34 patients), and K/LTX primarily occurred in patients
younger than 20 years (32 out of 42 patients). KTXare supplied by UNOS, the codes were relatively inclu-
patients were more evenly distributed.sive. However, because follow-up in the UNOS system
Life table analysis of patient survival in the TX andis not mandatory, outcome data may be less reliable.
NoTX groups showed a marked and persistent differenceInformation was also obtained from the North Ameri-
at all time periods. Projected survival of the NoTX group,can Pediatric Renal Transplantation Cooperative Study
by life table analysis (40% at five years and 20% at nine(NAPRTCS) as to which centers had PH patients coded.
years) differed from the transplanted group, which wasEach center was contacted, and we contacted those giving
89% at five years and 63% at nine years (P , 0.0001 byspecific permission for detailed data about 34 PH patients
both log-rank and Wilcoxon analyses).with KTX and K/LTX and their course. The NAPRTCS
Considering KTX preceding combined kidney-liverdatabase is voluntary, and thus, it may not be completely
transplant (K/LTX) as a separate “case,” the curve ofinclusive, even within those centers providing informa-
the 62 KTX patients’ survival was better (84% at 6 yearstion. The personal communication assured that those
and 55% at 9 years) than that of the 42 K/LTX (55%
included had relatively correct follow-up information.
at 6 years and 40% at 9 years, with only one patient
The UNOS and NAPRTCS data were used to search remaining between these years, P , 0.005; Fig. 2). This
the USRDS database, to add patients not previously projected K/LTX patient survival curve was not different
identified in the USRDS as having PH, and to correct from the NoTX group (P , 0.67 by log-rank and P ,
some data in the USRDS files. The final number of pa- 0.72 by Wilcoxon analysis). When patients who later
tients for analysis was 128. Considering the course of pa- received a TX are considered NoTX before that time,
tients with KTX prior to K/LTX as separate KTX records there are 128 cases in which the age is 25.64 6 17.5, not
for some calculations, the total number of “cases” was differing from the KTX group (P , 0.44), although the
138 USRDS patients, 62 of whom received KTX, 42 who survival curve still differs. The LTX group is significantly
received K/LTX, and 34 who received NoTX. When younger (14.31 6 14) than the NoTX group, but the
patients who ultimately received TX were considered survival curve does not differ (P , 0.67).
NoTX for the period between ESRD and TX, there were To obtain age-comparable groups, patients (not cases)
can be separated at 20 years. For more than 20 years,128 NoTX and a total of 232 cases (Table 1).
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Table 1. Summary of all database groups
K/LTX
Transplant group KTX Primary Secondary Total NoTX Total
USRDS Dx 5 PH 96 X X X 139 235
USRDS Dx 5 Px plus others 124 X X X 156 280
USRDS total , 55 years, after 1984 44 17 34 95
UNOS total K/LTX for PH 0 27 7 34 34
NAPRTCS total PH 16 10 8 18 0 34
PH only in UNOS 0 16 0 16 0 16
PH only in NAPRTCS 8 3 0 3 0 11
PH in both UNOS & NAPRTCS 0 4 1 5 0 5
All PH patients, ,55 years, after 1984 52 32 10 42 34 128
All PH cases, ,55 years, after 1984 62 32 10 42 34 138
All cases plus NoTX pre-Tx 62 32 10 42 128 232
Abbreviations are: Tx, transplant; K, kidney; L, liver; USRDS, United States Renal Data System; Dx, ?; PH, primary hyperoxaluria; UNOS, United Network for
Organ Sharing; NAPRTCS, North American Pediatric Renal Transplantation Cooperative Study.
Table 2. Results of three databases, for patients ,55 years, diagnosed after 1984
K/LTX
Transplant group KTX Primary Secondary Total NoTX Total
All PH cases, ,55 years, .1984 62 32 10 42 34 138
Lifetable survival @ 6 years 84% 65% 43% 56% 50%
Total # surviving 47 25 5 29 15 91
Total # dying 15 7 5 13 19 47
Final % surviving 0.76 0.78 0.50 0.69 0.44 0.66
Lifetable graft survival @ 6 years 50% 65% 43% 56% 104
Total grafts surviving 30 25 5 29 59
Grafts failing 32 7 5 13 45
Final % surviving 0.48 0.78 0.50 0.69 0.57
All cases plus NoTx pre-Tx 62 32 10 42 128 232
Lifetable survival @ 6 years 84% 65% 43% 56% 50%
Total # surviving 47 25 5 29
Total # dying 15 7 5 13
Final % surviving 0.76 0.78 0.50 0.69
Fig. 1. Age distribution in primary hyperoxa-
luria (PH) patients from USRDS, NAPRTCS,
and UNOS databases from 1986 through 1996,
differentiating kidney transplant (KTX; ),
kidney/liver transplant (K/LTX; h), and no
transplant (NoTX; j) groups of patients. The
predominance of younger ages is seen in trans-
plant patients, particularly K/LTX patients, in
contrast to the nontransplanted group (P ,
0.001).
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Fig. 2. Life table analysis of patient survival
for PH in patients. KTX patients have signifi-
cantly greater life projection than K/LTX and
NoTX groups. The differences between curves
are significant at P , 0.0004. Graphical trunca-
tion of NoTX and K/LTX curves at six years
was performed to avoid the effect of insignifi-
cant patient numbers in later years.
KTX patients’ ages are similar to NoTX patients (37.57 6 KTX (44% at 6 years and 33% at nine years, P , 0.91;
Fig. 3).11.05 vs. 42.2 6 9.64 year, P , 0.08), but life table survival
In PH patients, the duration of dialysis for ESRD priorcurves differ significantly (P , 0.0001). Likewise, the
to TX was 1.12 6 1.1 years. (KTX 1.01 6 0.9, all K/LTXages of K/LTX patients of less than 20 years (7.9 6 6
patients 1.79 6 2.0 years, primary K/LTX 1.05 6 0.7years) do not differ from KTX patients of less than 20
years, P , 0.43). There was no demonstrable differenceyears (9.6 6 7, P , 0.32), but the survival curves still
for duration of dialysis between TX patients who dieddiffer significantly (P , 0.03).
(1.31 6 1.28, median 0.58) and those who were aliveThe cumulative survival figures over the entire time
(1.05 6 1.04, median 0.88) before KTX or K/LTXperiod of the study showed that 46 of 62 KTX patients
(P , 0.95).(74%), 29 of 42 KLTX patients (69%), and 15 of 34
NoTX patients (44%) survived. The small numbers of
KLTX patients with greater than six years of follow- DISCUSSION
up explain the significantly differing curves with similar This is the first comprehensive review of TX in PH
projected final numbers. patients in the United States, to our knowledge. From the
The comparison of the UNOS K/LTX PH patients data obtained, it is apparent that so far, after the onset
with the total group of K/LTX patients showed that the of renal failure, belonging to the renal TX group offers
(34) PH patients had a five-year 60% life table survival, a far better chance of projected patient survival in PH
virtually the same as that of the 282 non-PH K/LTX than belonging to the NoTX group. A causative relation-
patients. ship cannot be implied, only an association. Selection
First, transplant KTX patient survival for 29 USRDS bias could be responsible. Difference in ages between
patients had been analyzed in 1994 [8]. At that time, it the TX and NoTX groups could reflect such a selection
appeared that living-related transplant might result in bias, although the expansion of the database by including
better patient survival than cadaver transplant (P 5 the pre-TX period as NoTX makes the ages of KTX and
0.058). Updated data on these same patients showed a NoTX patients similar, but life table curves still differ.
convergence of curves (P , 0.97). The number of pa- Furthermore, dividing patients at ages of less than 20
tients receiving cadaver KTX in the NAPRTCS data- years from those with more than 20 years allows a com-
base, in which certainty of outcome data is more likely, parison between KTX and K/LTX, in which ages are
was too few for analysis. similar but life table survival for KTX is still greater than
Specific data on kidney survival was not available for K/LTX (P , 0.03). Selection bias could also result from
K/LTX patients. Because in the patient with K/LTX we diagnostic error, mistaking secondary oxalosis in the
have given K/LTX the benefit of assuming kidney graft older patient for PH. We have therefore truncated the
survival if the patient survives, we used patient survival entire database at age 55 and examined the hospitaliza-
for K/LTX compared with kidney graft survival for KTX. tion records of the USRDS patients for inconsistencies.
By these criteria, kidney graft survival curves did not There is little support in the literature for isolated
cadaveric kidney transplant for PH. However, from thesediffer between K/LTX (56% at 6 years) and isolated
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Fig. 3. Life table analysis of kidney transplant
graft survival for PH patients. Curves do not
differ between KTX and K/LTX (P 5 0.91).
data, statistical analysis does not demonstrate different of the B6-response has not been finalized, it was an issue
recently addressed by the Fifth International Workshoppatient life survival for cadaver than live-donor kidney
transplant. Because of the fewer cadaveric transplants, on Primary Oxaluria (March 12–13, 1999, Zurich, Swit-
zerland). Normalization or a sustained 50% decrease inthe life table curves of graft survival could not be shown
to differ. In the direct experience of the authors and urine oxalate excretion or in the plasma oxalate/creati-
nine or glyoxalate/creatinine ratio (thus correcting forcontacts with other centers, it appears that successful
cadaver transplant for PH remains quite rare. Isolated renal function) [14], after two to three weeks of large
(.500 mg/1.73 m2) daily doses of B6, will imply a B6kidney transplant for PH still appears to have reasonable
success in this pooled series, 50% graft survival at five response, making liver replacement unnecessary.
The European approach is directed to K/LTX almostyears, as in our previous reports, when a strict protocol
is followed [9, 10]. Note that the NAPRTCS data on exclusively [13], and recent results support its continua-
tion [3]. The European data on isolated renal TX in PHnon-PH pediatric long-term patient (94% at five years
in LRD) and graft (73% in LRD) survival for renal TX were derived before the modern era [2], showing a three-
year graft survival of 23% in living related donorsshows patterns similar to those observed for PH patients
(87% at five years for patient survival and 51% at six (LRDs) and 17% in cadaveric grafts following conven-
tional transplant protocol. The causes of graft loss in theyears for all grafts). The rate of long-term graft success
in PH has been found independent of the activity levels majority of the cases were rejection (33%) and recurrence
of the primary renal disease (31%). A general update ofof alanine-glyoxylate-amino-transferase AGT [11].
Kidney/LTX for the PH patient with ESRD is attrac- data in children was performed in 1993 [14], showing a
five-year graft survival of 38% of 9 LRDs and 26% of 37tive and potentially curative. Although clinical details
are not available, K/LTX is still a hazardous venture in cadaveric grafts in PH patients transplanted after 1985,
which contrasts with the 71% graft survival for trans-the United States, no matter if it is performed in the
first instance or following a failed kidney transplant. The plants performed in 1986 for the total pediatric popula-
tion in the EDTA-ERA registry. No updates of the dataconsiderable risk of combined kidney-liver transplant
for PH patients in the United States requires special have been made to this date. Factors including predomi-
nance of cadaveric transplant in Europe and the absenceattention to the indications for the procedure [10]. Be-
cause plasma oxalate determination is not widely avail- of an appropriate protocol for PH in earlier years may
explain the differences between Europe and USA inable in the United States but may be necessary to rule
out vitamin B6 response, in many cases it is not clear terms of renal TX for PH [15].
The recent results of the European experience forthat a K/LTX “cure” is actually necessary. K/LTX is
unreasonable without excluding the B6 response, by oxa- K/LTX for PH (1984 to 1997) [3] showed a two- and five-
year patient survival of 80 and 72%, respectively, and alate and/or glycolate assay [12], relative to plasma creati-
nine in the ESRD patient. While a consensus definition renal graft survival of 78 and 62% at the same time
Saborio and Scheinman: TX for primary hyperoxaluria 1099
Fig. 4. Treatment choices for PH (adapted
with permission from Pediatric Transplanta-
tion 1:4–7, 1997).
points. Note that this is approximately the same graft Until a more cooperative effort is made in the United
States that decreases patient mortality, special considera-survival that we derived for primary K/LTX patients in
the United States. At six years, our analysis of the U.S. tions should be made to clarify the specific indications
for K/LTX in the management of the disease (Fig. 4).experience showed a two- and five-year K/LTX patient
survival of 79 and 55%, respectively, and an isolated Our suggestion is that in the United States, K/LTX
kidney graft survival of 55% at five years. If indeed the should be performed in those PH patients who have no
life table curves differ between this and the European response to B6, prolonged renal failure (more than 2
series, the reasons for apparently better patient survival years), a failing KTX from oxalosis (with no LRD kidney
in the European series are not known, as the specific available), and in those PH patients initially developing
causes of death in our series are not clarified, nor are the ESRD who have no KTX donor available. In this sense,
conditions of the patients at the time of transplant. The special efforts are necessary to improve universal pyri-
cumulative mortality of European K/LTX patients after doxine response testing in the patients and meticulous
10 years was 23%, and for our U.S. series, it was 31%. monitoring of the oxalate levels in the transplant.
Jamieson felt that the time of dialysis and clinical con-
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